Results 41 to 50 of about 1,864 (133)

Association of aortic and main left coronary aneurysms with severe aortic insufficiency in Takayasu’s arteritis

Clinics and Practice, 2011
Takayasu’s arteritis is a granulomatous vasculitis of unknown etiology that affects mainly the aorta and its branches. As a result of intimal fibroproliferation, segmental stenosis, occlusion, dilatation, and aneurysmal formation of the involved vessels ...
Marcelo Ferraz de Freitas, Marcelo Valladão de Carvalho, Marcelo Derbli Schafranski   +2 more
doaj   +1 more source

Is prolonged febrile syndrome associated with reactive thrombocytosis a possible association in the diagnosis of Takayasu’s arteritis? A case report

Journal of International Medical Research, 2021
Takayasu’s arteritis is a rare, systemic, inflammatory vasculitis of large blood vessels with an unknown aetiology that more frequently affects women of childbearing age with progression to stenosis, fibrosis or thrombogenesis.
Victoria Birlutiu, Rares-Mircea Birlutiu, Mariana Sandu, Emmanuel Mihali-Oniga   +3 more
doaj   +1 more source

Granulomatous Vasculitis: An Unusual Manifestation of Metastatic Crohn’s Disease

Australasian Journal of Dermatology, EarlyView.
Ethan Wei Min Lee, Helen Yiling Sun, Christopher W. Toon, Lachlan Andrew Byth   +3 more
wiley   +1 more source

The Role of Extracorporeal Membrane Oxygenation in Cardiopulmonary Dysfunction Due to Rheumatologic Diseases: A Systematic Review

ACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Objective This systematic review documents the current status of extracorporeal membrane oxygenation (ECMO) use in patients with complications of rheumatologic diseases. Methods Following Preferred Reporting Items for Systematic Reviews and Meta Analyses 2020 guidelines, we conducted a systematic review of studies published from January 2019 to ...
Kari L. Falaas, Lyubov Y. Tiegs, Nicole Theis‐Mahon, Elie Gertner   +3 more
wiley   +1 more source

Takayasu’s Arteritis with Systemic Lupus Erythematosus: A Rare Association

Case Reports in Rheumatology, 2015
We report the case of a 24-year-old nondiabetic, nonhypertensive lady with history of fatigue, dyspnoea and limb claudication. She has been diagnosed with Takayasu’s arteritis.
Dhrubajyoti Bandyopadhyay, Vijayan Ganesan, Debarati Bhar, Diptak Bhowmick, Sibnarayan Sasmal, Cankatika Choudhury, Sabyasachi Mukhopadhyay, Adrija Hajra, Manas Layek, Partha Sarathi Karmakar   +9 more
doaj   +1 more source

Atypical Tolosa Hunt syndrome with bilateral sclerokeratitis and optic atrophy in Takayasu's arteritis

American Journal of Ophthalmology Case Reports, 2017
Purpose: We report an interesting case of atypical Tolosa Hunt syndrome with bilateral Sclerokeratitis and optic atrophy in a patient with Takayasu's arteritis.
Kalpana Babu, Deepika C. Parameswarappa
doaj   +1 more source

Rare Gain‐of‐Function Variants in IDH1 and IDH2 Confer Increased Risk of Immune‐Mediated Rheumatic Diseases

ACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Objective Gain‐of‐function variants in IDH1 and IDH2 are enriched among individuals with coexisting myeloid neoplasms and autoimmune diseases. However, the association between IDH1/IDH2 variants and rheumatic diseases independent of hematologic neoplasms remains unclear. We investigated the association between rare gain‐of‐function and loss‐of‐function
Mahmut S. Kaymakci, Mehmet Hocaoğlu, Kenneth J. Warrington, Amr H. Sawalha   +3 more
wiley   +1 more source

Cerebral Embolic Activity in a Patient during Acute Crisis of Takayasu’s Arteritis

Case Reports in Neurology, 2012
Takayasu’s arteritis is a disease that affects large vessels and may cause neurological symptoms either by stenoses/occlusions or embolisms from vessels with an inflammatory process.
Ricardo de Carvalho Nogueira, Edson Bor-Seng-Shu, Paulo Eurípedes Marchiori, Manoel Jacobsen Teixeira   +3 more
doaj   +1 more source

Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis

ACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials. We aimed to evaluate the frequency, severity, and outcomes of vasculitis flares and irAEs in this population.
Juan Sevillano, Noha Abdel‐Wahab, Yixuan Zhou, Juan I. Ruiz, Maria E. Suarez‐Almazor   +4 more
wiley   +1 more source

Janus Kinase inhibitors in the treatment of large vessel vasculitis: a systematic review and meta-analysis

Open Medicine
This meta-analysis evaluates Janus Kinase (JAK) inhibitors’ efficacy and safety in large vessel vasculitis (LVV), encompassing Giant Cell Arteritis (GCA) and Takayasu’s Arteritis (TAK).
Bai Yang, Wang Zhe, Zhang Chunling
doaj   +1 more source